UBAC1

UBAC1 (KPC2) is a multidomain adaptor subunit of the KPC ubiquitin ligase complex that couples polyubiquitylated substrates to E3-mediated degradation during cell cycle control (PMID:16227581). It binds the catalytic subunit KPC1 through its UBL domain and engages the 26S proteasome through its UBL and N-terminal UBA domains, while its UBA domains capture polyubiquitylated cargo (PMID:16227581); the KPC1 interaction stabilizes KPC1 in a manner requiring the UBAC1 STI1 domain (PMID:16227581). Functionally, UBAC1 drives degradation of the CDK inhibitor p27 at G1: its STI1 domain is required for efficient p27 polyubiquitylation in vitro, and its N-terminal UBA domain is essential for p27 degradation in cells (PMID:16227581). Beyond cell-cycle control, UBAC1 is recruited to the C-terminal cytoplasmic region of CD95 (Fas) independently of CD95L, where it acts as an adaptor to bring together KPC1 and RelA, promoting partial proteolysis of p105 (NF-κB1) into p50 and formation of inhibitory p50 homodimers that repress NF-κB transcription (PMID:34917906); loss of CD95 releases UBAC1, limiting p50/p50 formation and de-repressing NF-κB-driven cytokine production in triple-negative breast cancer cells (PMID:34917906).

1. 2005 High

   Established UBAC1 as the substrate- and proteasome-bridging subunit of the KPC ligase by defining which domains contact KPC1, the proteasome, and ubiquitin chains.

   Evidence Co-immunoprecipitation, domain-deletion mutants, and in vitro polyubiquitylation in cells

   PMID:16227581

   Open questions at the time

   • No structural model of the UBL/UBA-domain interactions
   • Affinity and chain-linkage selectivity of the UBA domains not quantified
2. 2005 Medium

   Showed that UBAC1 binding does not merely scaffold but stabilizes the catalytic partner KPC1, identifying the STI1 domain as the determinant of this stabilization.

   Evidence STI1-deletion mutants with KPC1 protein-stability readout on co-expression

   PMID:16227581

   Open questions at the time

   • Mechanism by which STI1 stabilizes KPC1 unresolved
   • Single publication, no orthogonal stability assay reported
3. 2005 High

   Mapped the domain requirements for catalytic output versus cargo handling, distinguishing the STI1 domain (required for p27 polyubiquitylation) from individual UBA domains (dispensable in vitro).

   Evidence In vitro reconstituted ubiquitylation with domain-deletion mutants

   PMID:16227581

   Open questions at the time

   • Why STI1 is needed for polyubiquitylation mechanistically unclear
   • In vitro requirements not fully matched to cellular requirements
4. 2005 High

   Connected UBAC1 to a defined physiological output by demonstrating its requirement for G1 p27 degradation and pinpointing the N-terminal UBA domain as essential in cells.

   Evidence RNAi knockdown with domain-mutant rescue and cell-cycle analysis

   PMID:16227581

   Open questions at the time

   • Other physiological substrates beyond p27 not identified
   • Discrepancy between cellular UBA requirement and in vitro dispensability unexplained
5. 2021 Medium

   Extended UBAC1 function beyond the cell cycle by identifying it as a CD95 interactor that acts as an adaptor coupling KPC1 and RelA to control NF-κB signaling.

   Evidence Unbiased proteomics, reciprocal Co-IP with deletion constructs, and NF-κB reporter/p105-p50 immunoblot

   PMID:34917906

   Open questions at the time

   • Direct UBAC1-CD95 binding interface not structurally defined
   • Whether p105-to-p50 processing uses the same KPC catalytic mechanism as p27 unknown
   • Single lab
6. 2021 Medium

   Demonstrated the biological consequence of UBAC1 sequestration by showing CD95 loss releases UBAC1, reduces inhibitory p50 homodimers, and activates pro-inflammatory NF-κB output in TNBC.

   Evidence CD95 knockdown/knockout in TNBC cells with NF-κB activity and cytokine ELISA

   PMID:34917906

   Open questions at the time

   • In vivo relevance to tumor behavior not established
   • Quantitative link between UBAC1 availability and p50 dimer abundance not measured

• The full substrate repertoire of the UBAC1-KPC complex and the structural basis for how a single adaptor switches between cell-cycle (p27) and NF-κB (p105) regulatory programs remain unresolved.
• No structural model of UBAC1 in either complex
• Regulation of UBAC1 partitioning between KPC and CD95 contexts unknown
• Substrates beyond p27 and p105 uncharacterized in the available corpus